AAAAAA
Results:
1-14
|
Results: 14
Authors:
Gibson, KR
Thomas, SR
Rowley, M
Citation: Kr. Gibson et al., An intramolecular sulfoxide alkylation-elimination approach to the [1,2,3]triazolo[1,5-alpha]pyrimidine ring system, SYNLETT, (5), 2001, pp. 712-714
Authors:
Thomas, GV
Nye, R
Rowley, M
Robinson, EJ
Citation: Gv. Thomas et al., What is a picture? Children's conceptions of pictures, BR J DEV PS, 19, 2001, pp. 475-491
Authors:
Rowley, M
Bristow, LJ
Hutson, PH
Citation: M. Rowley et al., Current and novel approaches to the drug treatment of schizophrenia, J MED CHEM, 44(4), 2001, pp. 477-501
Authors:
Rowley, M
Hallett, DJ
Goodacre, S
Moyes, C
Crawforth, J
Sparey, TJ
Patel, S
Marwood, R
Patel, S
Thomas, S
Hitzel, L
O'Connor, D
Szeto, N
Castro, JL
Hutson, PH
MacLeod, AM
Citation: M. Rowley et al., 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist, J MED CHEM, 44(10), 2001, pp. 1603-1614
Authors:
Crawforth, J
Goodacre, S
Maxey, R
Bourrain, S
Patel, S
Marwood, R
O'Connor, D
Herbert, R
Hutson, P
Rowley, M
Citation: J. Crawforth et al., 3-(4-piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists, BIOORG MED, 10(24), 2000, pp. 2701-2703
Authors:
Collins, I
Davey, WB
Rowley, M
Quirk, K
Bromidge, FA
McKernan, RM
Thompson, SA
Wafford, KA
Citation: I. Collins et al., N-(indol-3-ylglyoxylyl)piperidines: High affinity agonists of human GABA-Areceptors containing the alpha(1) subunit, BIOORG MED, 10(12), 2000, pp. 1381-1384
Authors:
Ravenscroft, N
Reeves, J
Rowley, M
Citation: N. Ravenscroft et al., Leisure, property, and the viability of town centres, ENVIR PL-A, 32(8), 2000, pp. 1359-1374
Authors:
Hallett, DJ
Gerhard, U
Goodacre, SC
Hitzel, L
Sparey, TJ
Thomas, S
Rowley, M
Ball, RG
Citation: Dj. Hallett et al., Neighboring group participation of the indole nucleus: An unusual DAST-mediated rearrangement reaction, J ORG CHEM, 65(16), 2000, pp. 4984-4993
Authors:
Rowley, M
Liu, PC
Van Ness, B
Citation: M. Rowley et al., Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan, BLOOD, 96(9), 2000, pp. 3175-3180
Authors:
Moore, KW
Bonner, K
Jones, EA
Emms, F
Leeson, PD
Marwood, R
Patel, S
Patel, S
Rowley, M
Thomas, S
Carling, RW
Citation: Kw. Moore et al., 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D-4 receptors, BIOORG MED, 9(9), 1999, pp. 1285-1290
Authors:
Ahmed, A
Clayden, J
Rowley, M
Citation: A. Ahmed et al., 1,3,4,5-tetrahydroazepin-2-ones by dearomatising anionic cyclisation of N-allyl-1-naphthamides, SYNLETT, (12), 1999, pp. 1954-1956
Authors:
Zimmet, P
Turner, R
McCarty, D
Rowley, M
Mackay, I
Citation: P. Zimmet et al., Crucial points at diagnosis - Type 2 diabetes or slow type 1 diabetes, DIABET CARE, 22, 1999, pp. B59-B64
Authors:
van Niel, MB
Collins, I
Beer, MS
Broughton, HB
Cheng, SKF
Goodacre, SC
Heald, A
Locker, KL
MacLeod, AM
Morrison, D
Moyes, CR
O'Connor, D
Pike, A
Rowley, M
Russell, MGN
Moyes, CR
O'Connor, D
Pike, A
Rowley, M
Russell, MGN
Sohal, B
Stanton, JA
Thomas, S
Verrier, H
Watt, AP
Castro, JL
Citation: Mb. Van Niel et al., Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles, J MED CHEM, 42(12), 1999, pp. 2087-2104
Authors:
Willis, J
Scott, R
Brown, L
Zimmet, P
MacKay, I
Rowley, M
Citation: J. Willis et al., Type 1 diabetes in insulin-treated adult-onset diabetic subjects, DIABET RE C, 42(1), 1998, pp. 49-53
Risultati:
1-14
|